Firtecan pegol Uses, Dosage, Side Effects and more
Firtecan pegol is under investigation in clinical trial NCT01036113 (A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Firtecan pegol |
| Generic | Firtecan pegol |
| Firtecan pegol Other Names | Firtecan pegol |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
